Artia Global Partners LP
CIK 1937964
13F filing for Q2 2026・No. 3,706
- Holdings
- US$541.86M
- Quarter change
- +US$42.44M
- Entries
- 48
- Net bought (estimate)
- +US$55.77M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 7
- Sold out 8
- Cut 3
- Added 11
- Corporate actions 0
- Unchanged 26
Largest holdings
47 stocks worth US$526.03M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| ABIVAX SASPONSORED ADS | Cut | 516,447 | US$68.82M | 13.08% |
| INSMINSMED INCCOM PAR $.01 | Cut | 589,052 | US$62.8M | 11.94% |
| TREVI THERAPEUTICS INCCOM | Added | 2,210,852 | US$41.23M | 7.84% |
| BRIGHTSPRING HEALTH SVCS INCCOM | Added | 517,315 | US$36.08M | 6.86% |
| RVMDREVOLUTION MEDICINES INCCOM | Added | 185,390 | US$34.72M | 6.60% |
| ARGXARGENX SESPONSORED ADR | Unchanged | 29,739 | US$27.59M | 5.25% |
| ALKSALKERMES PLCSHS | New | 448,964 | US$23.52M | 4.47% |
| TRAVERE THERAPEUTICS INCCOM | Added | 339,033 | US$19.26M | 3.66% |
| AZNASTRAZENECA PLCORD | Added | 98,376 | US$18.65M | 3.55% |
| NAMSNEWAMSTERDAM PHARMA COMPANYORDINARY SHARES | Unchanged | 503,936 | US$17.08M | 3.25% |
Sign in (free) to see its 47 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.